XML 65 R40.htm IDEA: XBRL DOCUMENT v3.23.1
Dispositions (Details Textual)
₩ in Millions, $ in Millions
1 Months Ended 3 Months Ended
Apr. 30, 2022
USD ($)
Mar. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2022
KRW (₩)
Mar. 31, 2022
Samsung Bioepis          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Equity, ownership interest   49.90%     49.90%
Samsung Bioepis | Fair Value, Recurring          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Other current assets, receivable   $ 809.9 $ 798.8    
Other assets, receivable   $ 411.6 $ 405.4    
Samsung Bioepis | Payment Due At First Anniversary | Discount rates | Fair Value, Recurring          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Risk-adjusted discount rates   0.059      
Samsung Bioepis | Payment Due At Second Anniversary | Discount rates | Fair Value, Recurring          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Risk-adjusted discount rates   0.058      
Samsung Bioepis          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Proceeds from divestiture of interest in joint venture $ 1,000.0        
Payables to divestiture of interest in joint venture 1,300.0        
Gain on sale of equity interest in Samsung Bioepis   $ 1,500.0      
Cumulative translation loss   58.9      
Gain on derivative used in net investment hedge   57.0      
Additional milestone payment 50.0        
Investment in Samsung Bioepis | ₩       ₩ 581.6  
Samsung Bioepis | Payment Due At First Anniversary          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Payables to divestiture of interest in joint venture 812.5        
Gain (loss) on sale   11.1      
Samsung Bioepis | Payment Due At Second Anniversary          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Payables to divestiture of interest in joint venture $ 437.5        
Gain (loss) on sale   $ (6.2)